搜索优化
English
搜索
图片
Copilot
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Outsourcing-pharma
1 小时
Driving innovation in clinical trials: Patient perspectives and multidimensional assessments
Challenges persist, as the clinical research sector can be slow to adopt these innovations. Comprehensive evidence and ...
Outsourcing-pharma
1 小时
Overcoming clinical trial obstacles with AI: WCG’s outlook for SCOPE 2025
Explore WCG's cutting-edge AI and tech solutions, including ClinSphere Total Enrollment, transforming clinical trials at ...
Outsourcing-pharma
2 小时
Decentralized clinical trials take the spotlight at SCOPE 2025
Discover Medable's latest advancements in decentralized clinical trials, including AI-driven tools and enhanced eCOA ...
Outsourcing-pharma
2 天
Johnson & Johnson acquires Intra-Cellular for $14.6bn
Johnson & Johnson's $14.6bn acquisition of Intra-Cellular Therapies adds Caplyta and a robust pipeline targeting major ...
Outsourcing-pharma
2 天
Scope Summit finalists to fight for awards in site innovation and patient engagement
Spotlighting innovation at the SCOPE Summit, finalists for the Site Innovation and Patient Engagement Awards showcase ...
Outsourcing-pharma
7 天
Verdiva Bio launches with $411m in funding to advance obesity drugs
Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an ...
Outsourcing-pharma
7 天
India’s Anthem Biosciences plans $397m IPO
As India’s contract manufacturing and development organization (CDMO) is set to double in the next decade, Anthem Biosciences ...
Outsourcing-pharma
9 天
Denali Therapeutics’ ALS drug fails to improve function and survival in phase 2/3 trial
Denali Therapeutics' DNL343 fails to slow ALS progression in phase 2/3 trial but shows safety and offers insights for future ...
Outsourcing-pharma
10 天
Orbis Medicines bags €90 million Series A to develop oral competitors of biologics
Orbis Medicines secures €90M Series A to develop innovative oral macrocycles, offering cost-effective alternatives to ...
Outsourcing-pharma
1 个月
AstraZeneca claims phase 3 success with combination therapy for prostate cancer
High-level results from an ongoing clinical trial make Astrazeneca’s combination treatment the first to show benefit in a subtype of prostate cancer. AstraZeneca has reported positive results from the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈